, Inc. (OTCQB: CIIX) is a multi-sector business that is engaged in Chinese-based website financial information and cannabis distribution. Shares of the Chinese-language based company are declining 10.04%, through afternoon trading on Monday, February 27, 2017. Over the past three months,, Inc. has seen average daily volume of 174,616 shares. However, volume of 234,276 shares or dollar volume of $290,502, has already exchanged hands through late trading Monday.

Shares of, Inc. are under pressure Monday, after the company announced that its CEO, Warren Wang, attended and presented at the 18th Annual Yibao Biologics’ Conference. In addition, the conference proved to be a great resource on building a direct sales team in China. The company hopes to expand its CBD oil business within China. Here is the full press release detailing of the conference and direct China sales plan:, Inc. Press Release:

NEW YORK, Feb.  27, 2017 /PRNewswire/ — (CIIX) (“CIIX” or the “Company”), the premier financial information website for Chinese-speaking investors, today announces that company CEO Warren Wang attended Shangdong Yibao Biologics Co. Ltd.’s annual conference, and, by invitation, delivered a five-minute speech to celebrate the 18th anniversary of Yibao Biologics.

Yibao Biologics is a modern high-tech enterprise which specializes in the research, production and sales of chondroitin sulfate series and Confucian series health care products. The company is also the largest and most professional manufacturer of chondroitin sulfate in the world. Yibao Biologics invited to participate in its annual direct sales conference to discuss the development and prospects of Chinese health products enterprises in the United States.

As an attendee of the conference, Wang learned how direct sales of the health products industry operate in China, and how to apply this information to build the sales team of CIIX’s retail website. He also delivered a five-minute speech at the conference and received continuous applause from more than 5,000 direct sales persons in attendance.

“The market for direct selling of natural products in the United States has considerable depth, and varies from the Chinese market in many ways. It was an honor to attend this year’s Yibao Biologics conference, where I was able to gain valuable market insight as well as present my own expertise to fellow attendees,” says Wang. recently launched, marking the company’s official entry into the CBD hemp oil markets.

“ will continue to sell CBD health products through online retailing methods to the world’s nearly 1.4 billion Chinese people. Additionally, we will gradually open offline selling channels and combine word-of-mouth marketing with Internet retailing. Our goal is to benefit more Chinese people with reliable logistics network and commodity channels, as well as to provide leading positions in products and resources. Due to the huge size of the Chinese direct selling market, we hope to further expand our market share through investment and alliance in and with direct selling companies,” concludes Wang.

About, Inc. (CIIX)

Founded in 1999, endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) support services to our various partners; (c) consulting services to smaller private companies considering becoming a public company; and (d) advertising and public relation related support services.

Add a Comment to this Post